VYNE Therapeutics Inc.

VYNE · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$19,926$30,620$30,908$42,250
Short-Term Investments$41,590$62,633$0$0
Receivables$0$0$5,000$7,583
Inventory$0$0$0$7,291
Other Curr. Assets$2,921$2,710$2,367$6,062
Total Curr. Assets$64,437$95,963$38,275$63,186
Property Plant & Equip (Net)$206$207$0$354
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$2,262$1,515$2,483$3,506
Total NC Assets$2,468$1,722$2,483$3,860
Other Assets$0$0$0$0
Total Assets$66,905$97,685$40,758$67,046
Liabilities
Payables$2,707$1,659$2,386$6,510
Short-Term Debt$99$115$0$349
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$12,013$5,764$6,959$11,551
Total Curr. Liab.$14,819$7,538$9,345$18,410
LT Debt$0$99$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$1,313$211$0
Total NC Liab.$0$1,412$211$0
Other Liabilities$0$0$0$0
Cap. Leases$99$214$0$349
Total Liabilities$14,819$8,950$9,556$18,410
Equity
Pref Stock$0$0$0$0
Common Stock$1$1$0$5
Retained Earnings-$731,170-$691,336-$662,735-$639,525
AOCI$20$26$0$0
Other Equity$783,235$780,044$693,937$688,156
Total Equity$52,086$88,735$31,202$48,636
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$66,905$97,685$40,758$67,046
Net Debt-$19,827-$30,406-$30,908-$41,901
VYNE Therapeutics Inc. (VYNE) Financial Statements & Key Stats | AlphaPilot